| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | -65.6% |
| R&D Expense | $14.5M | -13.1% |
| SG&A Expense | $10.4M | -6.5% |
| Operating Income | -$23.8M | +3.4% |
| Net Income | -$22.9M | -9.3% |
| EPS (Basic) | -$0.11 | -10.0% |
| EPS (Diluted) | -$0.11 | -10.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -29.9% |
| Short-term Investments | $9.0M | -59.1% |
| Current Assets | $15.5M | -55.0% |
| Total Assets | $25.1M | -44.0% |
| Current Liabilities | $2.6M | -38.8% |
| Total Liabilities | $5.9M | -28.4% |
| Stockholders' Equity | $19.2M | -47.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.3M | +20.2% |
| Capital Expenditures | $218K | -75.6% |
| Investing Cash Flow | $13.2M | +171.5% |
| Financing Cash Flow | -$7K | -108.9% |
| Free Cash Flow | -$15.5M | +22.7% |